AMSTERDAM – Hepatitis B treatment guidelines, newly updated by the European Association for the Study of the Liver to help doctors navigate what EASL governing board member Frank Tacke told BioWorld Today is "lots of dynamic change" during the last couple years, have become the first to recommend the use of the most recently approved HBV drug, Vemlidy.